Does PEMBROLIZUMAB Cause Hepatic enzyme increased? 531 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 531 reports of Hepatic enzyme increased have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.6% of all adverse event reports for PEMBROLIZUMAB.
531
Reports of Hepatic enzyme increased with PEMBROLIZUMAB
0.6%
of all PEMBROLIZUMAB reports
45
Deaths
233
Hospitalizations
How Dangerous Is Hepatic enzyme increased From PEMBROLIZUMAB?
Of the 531 reports, 45 (8.5%) resulted in death, 233 (43.9%) required hospitalization, and 39 (7.3%) were considered life-threatening.
Is Hepatic enzyme increased Listed in the Official Label?
Yes, Hepatic enzyme increased is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which PEMBROLIZUMAB Alternatives Have Lower Hepatic enzyme increased Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G